Latest Regulation News

Ark Mines has secured Environmental Authority approval for its Sandy Mitchell Rare Earths project in Queensland, marking a crucial step towards obtaining its Mining Licence. The company has also completed a major drilling program, setting the stage for an upcoming Pre-Feasibility Study.

Native Mineral Resources reports a successful ramp-up of gold production at its Blackjack plant, delivering nearly 700 ounces of refined gold and securing $10 million in fresh capital to fuel ongoing operations and exploration.

Challenger Limited reported a solid 4% increase in total Life sales to $2.5 billion in Q1 FY26, buoyed by strong annuity sales and strategic partnerships. The company reaffirmed its FY26 earnings guidance while highlighting upcoming regulatory changes expected to benefit the sector.

Eclipse Metals has commenced diamond drilling at its Greenland rare earth project, backed by a $4 million placement to expand and upgrade its resource. The move aligns with strategic plans for a Nasdaq dual listing amid growing global supply chain concerns.

Litchfield Minerals has addressed ASX concerns over recent share price spikes, confirming active drilling at its Oonagalabi project and requesting a trading halt pending assay results.

VHM Limited has reaffirmed the scale of its Goschen Project with updated Mineral Resource and Ore Reserve estimates, adopting a more cautious approach for Area 1 that enhances mine plan confidence while leaving substantial upside for future growth.

QBE Insurance Group has announced the redemption of its USD 300 million 6.10% fixed rate subordinated notes due 2045, marking a notable step in its capital management strategy with regulatory approval secured.

ABx Group’s ALCORE subsidiary is advancing its pilot plant infrastructure at Bell Bay, Tasmania, with major equipment designs completed and delivery slated for early 2026.

Resolute Mining has agreed to support the sale of its 31.45 million shares in Loncor Gold to Chengtun Mining Group for C$1.38 per share, a move that will strengthen its balance sheet and accelerate key African projects.

29Metals maintains steady copper output at Golden Grove despite seismic disruptions to zinc production, while progressing key growth projects and regulatory steps toward Capricorn Copper’s restart.

Argenica Therapeutics reports encouraging functional improvements in stroke patients treated with ARG-007, setting the stage for a targeted Phase 2b trial focused on patient-centered outcomes.

Cobalt Blue Holdings attributes its recent share price jump to a surge in cobalt prices driven by new export controls in the Democratic Republic of Congo, while confirming no undisclosed company information is influencing trading.